Passage Bio, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 11/14/2024 | 9.82 M | $6.88 M | -2.98% | 15.90% |
| LYNX1 CAPITAL MANAGEMENT LP | 11/14/2024 | 8.43 M | $5.90 B | 66.62% | 13.64% |
| VESTAL POINT CAPITAL, LP | 11/14/2024 | 6.10 M | $4.27 M | 0.79% | 9.88% |
| NEW LEAF VENTURE PARTNERS, L.L.C. | 11/13/2024 | 2.50 M | $1.75 M | 0.00% | 4.04% |
| 11/14/2024 | 2.46 M | $1.72 M | 0.00% | 3.98% | |
| VANGUARD GROUP INC | 11/13/2024 | 2.07 M | $1.45 M | 0.00% | 3.35% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2024 | 1.50 M | $1.05 M | 0.00% | 2.43% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 1.39 M | $974,992 | 23.75% | 2.26% |
| ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 961,271 | $671,000 | 0.00% | 1.56% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 721,735 | $505,215 | 100.00% | 1.17% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 556,142 | $389,299 | 0.00% | 0.90% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 509,516 | $356,732 | 18.19% | 0.82% |
| CITADEL ADVISORS LLC | 11/14/2024 | 402,525 | $281,768 | 154.34% | 0.65% |
| FIDUCIARY TRUST CO | 11/14/2024 | 215,000 | $150,500 | 0.00% | 0.35% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 163,859 | $114,701 | -78.18% | 0.27% |
| RBF CAPITAL, LLC | 11/14/2024 | 142,807 | $99,965 | 0.00% | 0.23% |
| STATE STREET CORP | 11/14/2024 | 123,873 | $86,711 | 0.00% | 0.20% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 98,041 | $68,629 | -5.60% | 0.16% |
| SHAY CAPITAL LLC | 11/14/2024 | 92,256 | $64,579 | 100.00% | 0.15% |
| DLK INVESTMENT MANAGEMENT, LLC | 10/09/2024 | 64,000 | $44,800 | 0.00% | 0.10% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 11/08/2024 | 53,915 | $37,741 | 100.00% | 0.09% |
| ENGINEERS GATE MANAGER LP | 11/14/2024 | 34,770 | $24,339 | 100.00% | 0.06% |
| XTX TOPCO LTD | 11/14/2024 | 29,590 | $20,713 | 73.66% | 0.05% |
| SQUAREPOINT OPS LLC | 11/14/2024 | 27,927 | $19,549 | 100.00% | 0.05% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 27,072 | $18,950 | -0.59% | 0.04% |
| CRESSET ASSET MANAGEMENT, LLC | 11/14/2024 | 23,725 | $16,608 | 0.00% | 0.04% |
| FMR LLC | 11/13/2024 | 22,852 | $15,997 | 8.54% | 0.04% |
| TWO SIGMA SECURITIES, LLC | 11/14/2024 | 21,635 | $15,145 | 100.00% | 0.04% |
| HIGHTOWER ADVISORS, LLC | 11/14/2024 | 16,380 | $11,000 | -23.86% | 0.03% |
| MORGAN STANLEY | 11/14/2024 | 13,442 | $9,410 | 0.00% | 0.02% |
| BARCLAYS PLC | 11/19/2024 | 13,153 | $9,000 | 0.00% | 0.02% |
| JANE STREET GROUP, LLC | 11/15/2024 | 12,271 | $8,590 | 100.00% | 0.02% |
| CITADEL ADVISORS LLC | 11/14/2024 | 7,700 | $5,390 | -7.23% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 5,030 | $3,521 | -61.90% | 0.01% |
| NORDWAND ADVISORS, LLC | 11/01/2024 | 2,500 | $1,750 | 100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 1,770 | $1,239 | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 425 | $298 | 15.80% | 0.00% |
| JPMORGAN CHASE & CO | 12/26/2024 | 273 | $191 | 0.00% | 0.00% |
| LRI INVESTMENTS, LLC | 11/15/2024 | 225 | $133 | 0.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 11/12/2024 | 64 | $45 | 100.00% | 0.00% |
| HARBOUR INVESTMENTS, INC. | 11/04/2024 | 60 | $42 | 0.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 11/14/2024 | 47 | $33 | 0.00% | 0.00% |
| ROYAL BANK OF CANADA | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| RHUMBLINE ADVISERS | 11/12/2024 | 0 | $0 | -100.00% | 0.00% |
| MARQUETTE ASSET MANAGEMENT, LLC | 10/08/2024 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| ACUITAS INVESTMENTS, LLC | 11/07/2024 | 0 | $0 | -100.00% | 0.00% |
| VERSANT VENTURE MANAGEMENT, LLC | 11/08/2024 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
Passage Bio, Inc.institutional Ownership - FAQ's
During the previous two years, 59 institutional investors and hedge funds held shares of Passage Bio, Inc.. The most heavily invested institutionals were:
ORBIMED ADVISORS LLC: 9.82 M
Lynx1 Capital Management LP: 8.43 M
Vestal Point Capital, LP: 6.1 M
New Leaf Venture Partners, L.L.C.: 2.5 M
VANGUARD GROUP INC: 2.07 M
TANG CAPITAL MANAGEMENT LLC: 1.5 M
62.61% of Passage Bio, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 38.72 M shares in the last 24 months. This purchase volume represents approximately $22.45 M in transactions.